A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis—a primary driver of ...

Dr. Naveen Chandra G SHOD and Lead Consultant - Department of Interventional Cardiology, Aster Whitefield Hospital, Bengaluru ...

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis - a primary driver of cardiovascular death worldwide - in large mammals, a study suggests.

In atherosclerosis, the vascular smooth muscle cell (VSMC) contributes to vessel wall inflammation and lipoprotein retention, as well as to the formation of the fibrous cap that provides stability ...

Atherosclerosis is when plaque forms in the arteries. This can lead to blood clots that may suddenly stop blood supply; when this affects the heart's... | Clinical And Molecular Dx ...